Financing channel feed – Endpoints News

Financing channel feed

Another day, another $100M-plus biotech megaround as radiopharmaceuticals’ popularity grows

7 years ago

Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round

7 years ago

Cambridge fund raises more than $196M in the UK's heftiest 2019 funding round

7 years ago

Pfizer biotech spinout nabs $125M megaround as Bain-backed syndicate bets on its late-stage game plan

7 years ago

Illicit drugs are making some big advances in R&D, and Thiel partners at ATAI get a $43M bankroll to fuel drive on magic mushrooms, Special K

7 years ago

Precision Bio wants to show there's a better way to edit genes — and now it has $126M in IPO cash to prove it

7 years ago

Promising to match more NSCLC patient with targeted drugs, Cambridge spinout Inivata readies US launch of liquid biopsy

7 years ago

As AI permeates clinical analytics, Perceptive Advisors bets $40M into a storied player in the field

7 years ago

Jim Mellon's Juvenescence takes a chance on tiny upstart run by former Pfizer exec

7 years ago

France's NASH contender Genfit leaps onto Nasdaq with $135M IPO

7 years ago

Contending for CD47 throne, Arch Oncology scores $50M as it ramps up PhI studies

7 years ago

Buyout vote looming, Celgene files for ozanimod OK (again), with a multibillion-dollar bet riding on every step

7 years ago

Bone-marrow focused Imago BioSciences scores $40M in Omega-led round

7 years ago

Shanghai-based cancer drugmaker Abbisko lines up $42M B round as it makes a leap for the clinic

7 years ago

Brexit who? Record investment last year fuels big spike in registered UK biotech firms

7 years ago

Flagship ties up a monster $824M fund to back a new wave of biotech startups seeded in their lab

7 years ago

Seeking a place among giants in the oncolytic virus field, little Cold Genesys bags $22M Series C

7 years ago

Arch-backed biotech hauls in a fast B round as its reborn anti-psychotic zooms to a PhII finish line

7 years ago

Months away from completing a key sickle cell trial, upstart Imara scores $63M in round co-led by Arix, Orbimed

7 years ago

South Korean investigators raid stock exchange in another Samsung BioLogics IPO probe — report

7 years ago

Surrozen banks $50M round to fuel its drive to the clinic with regenerative med platform

7 years ago

CEO of biotech investor Hercules Capital abandons his post in the midst of a college cheating scandal

7 years ago

Markets buzz as another mRNA biotech unicorn looks to carry home a record $800M IPO haul

7 years ago

Backed by OrbiMed, Lilly and now Advantech, China's InventisBio loads up $70M to propel cancer, metabolic pipeline

7 years ago

First page Previous page 114 115 116117118 119 120 Next page Last page